– WITH THE SUPPORT OF INSERM, GET EUROPEAN FUNDS
– LAST FUNDRAISE BEFORE CHANGING OUR FUNDING MODEL
The FET-Open call for projects, which is part of the Horizon 2020 program for research initiated by the European Commission, selects its laureates for their founding, transdisciplinary, breakthrough research objective. CC & C has been developing a solution for pancreatic cancer for several years based on the fundamentals of physical oncology. Today, in a consortium of teams from the Faculty of Medicine of Bichat (France), Universities of Mons (Belgium) and Patras (Greece), and under the patronage of INSERM (the French public research organization dedicated to health), the company is preparing to respond to this call.Other potential partners are still in talks to join the team, particularly in Germany. The budget, oscillating between 3 and 4 million euros spanning two years, would validate the original proposal (treat pancreatic cancer), but also open new avenues on other types of tumors. Appointment on May 15th for the filing of the file.